245 related articles for article (PubMed ID: 31587003)
21.
Ji X; Ding B; Wu X; Liu F; Yang F
Xenobiotica; 2021 Mar; 51(3):262-267. PubMed ID: 33115303
[TBL] [Abstract][Full Text] [Related]
22. Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes.
Wang M; Jiang W; Zhou J; Xue X; Yin C
Pharm Biol; 2020 Dec; 58(1):1064-1069. PubMed ID: 33103940
[TBL] [Abstract][Full Text] [Related]
23. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
[TBL] [Abstract][Full Text] [Related]
24. Effect of tubeimoside I on the activity of cytochrome P450 enzymes in human liver microsomes.
Wang R; Zheng K; Liu Y; Ji S; Tang Y; Wang J; Jiang R
Xenobiotica; 2024 Feb; 54(2):57-63. PubMed ID: 38166553
[TBL] [Abstract][Full Text] [Related]
25. In vitro study on the effect of cornin on the activity of cytochrome P450 enzymes.
Zhang Q; Qu Z; Zhou Y; Zhou J; Yang J; Li S; Xu Q; Zhou X
BMC Complement Med Ther; 2021 May; 21(1):138. PubMed ID: 33966625
[TBL] [Abstract][Full Text] [Related]
26. In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by Grandisin.
Habenschus MD; Moreira FL; Lopes NP; de Oliveira ARM
Planta Med; 2017 May; 83(8):727-736. PubMed ID: 28073119
[TBL] [Abstract][Full Text] [Related]
27. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
Bournique B; Lambert N; Boukaiba R; Martinet M
Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
[TBL] [Abstract][Full Text] [Related]
28.
Zhao H; Xue S; Meng Q; Zhou C
Xenobiotica; 2021 Sep; 51(9):977-982. PubMed ID: 34176447
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4.
Jin C; He X; Zhang F; He L; Chen J; Wang L; An L; Fan Y
Xenobiotica; 2015; 45(7):571-7. PubMed ID: 25811791
[TBL] [Abstract][Full Text] [Related]
30. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
Wen X; Wang JS; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
[TBL] [Abstract][Full Text] [Related]
31. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
[TBL] [Abstract][Full Text] [Related]
32. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
[TBL] [Abstract][Full Text] [Related]
33. Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes.
Wang H; Xia B; Lin M; Wang Y; Sun B; Li Y
Pharm Biol; 2020 Dec; 58(1):1150-1155. PubMed ID: 33327821
[TBL] [Abstract][Full Text] [Related]
34. In vitro evaluation of the inhibition potential of echinacoside on human cytochrome P450 isozymes.
Wu Y; Qiao A; Lin S; Chen L
BMC Complement Med Ther; 2022 Feb; 22(1):46. PubMed ID: 35180866
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the in vitro and in vivo metabolic pathway and cytochrome P450 inhibition/induction profile of Huperzine A.
Lin PP; Li XN; Yuan F; Chen WL; Yang MJ; Xu HR
Biochem Biophys Res Commun; 2016 Nov; 480(2):248-253. PubMed ID: 27751854
[TBL] [Abstract][Full Text] [Related]
36. Stereoselective interaction between tetrahydropalmatine enantiomers and CYP enzymes in human liver microsomes.
Sun SY; Wang YQ; Li LP; Wang L; Zeng S; Zhou H; Jiang HD
Chirality; 2013 Jan; 25(1):43-7. PubMed ID: 23001793
[TBL] [Abstract][Full Text] [Related]
37. Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.
Ericsson T; Sundell J; Torkelsson A; Hoffmann KJ; Ashton M
Xenobiotica; 2014 Jul; 44(7):615-26. PubMed ID: 24400699
[TBL] [Abstract][Full Text] [Related]
38. In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily.
Usmani KA; Karoly ED; Hodgson E; Rose RL
Drug Metab Dispos; 2004 Mar; 32(3):333-9. PubMed ID: 14977868
[TBL] [Abstract][Full Text] [Related]
39. Development of a method to determine cytochrome P450 1A2, 2C9, 2D6 and 3A4 activity sheep hepatic microsomes.
McBride GM; Soo JY; Varcoe T; Morrison JL; Wiese MD
J Pharmacol Toxicol Methods; 2020; 106():106934. PubMed ID: 33080390
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the
Giri P; Gupta L; Singh S; Patel N; Srinivas NR; Srivastva BK; Desai RC; Patel PR
Xenobiotica; 2019 Oct; 49(10):1164-1172. PubMed ID: 30488748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
